T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...
News-Medical.Net on MSN
Researchers uncover TRAT1's central role in T helper cell function
Researchers at the Medical University of Vienna have taken a closer look at a previously largely unknown component of the ...
An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...
A research team led by Cancer Center at Illinois (CCIL) member Hua Wang has published new research detailing a new mRNA ...
The Brighterside of News on MSN
Scientists re-engineer a patient’s own T cells to target and destroy cancer cells
Hodgkin lymphoma and other malignancies that express the CD30 protein have been the scourge of oncologists for decades. For patients whose cancer returns or is treatment-refractory, choices are ...
The ZUMA-24 study showed outpatient axicabtagene ciloleucel (axi-cel) for DLBCL reduced hospitalization and improved safety profiles. CAR T-cell therapy for DLBCL shows promise in outpatient settings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback